Segment Information (Tables)

3 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Summarized information concerning our reportable segments is shown in the following table (in thousands):

Three Months Ended March 31,	Knee		Hip		Biologics & Spine		Extremity		Other			Corporate			Total
2014
Net sales	$	20,567	$	10,804	$	5,822	$	19,671	$	6,394		$	—		$	63,258
Segment profit (loss)	1,938		942		34		4,507		(810		)	(7		)	6,604
Total assets, net	65,804		31,427		24,719		25,488		13,960			94,353			255,751
Capital expenditures	986		708		293		919		355			391			3,652
Depreciation and Amortization	2,013		706		303		532		151			965			4,670
2013
Net sales	$	20,502	$	10,440	$	6,057	$	15,683	$	6,619		$	—		$	59,301
Segment profit (loss)	1,910		844		194		3,729		(611		)	(715		)	5,351
Total assets, net	69,604		34,679		25,725		22,681		4,154			92,979			249,822
Capital expenditures	3,199		552		32		434		127			1,119			5,463
Depreciation and Amortization	1,894		676		337		428		116			1,084			4,535

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

Geographic distribution of our long-lived assets and inventory is shown in the following table (in thousands):

As of:	March 31, 2014						December 31, 2013
	Domestic			International			Domestic			International
Long lived assets, gross	$	141,499		$	43,183		$	139,406		$	41,857
Accumulated depreciation and amortization	(77,162		)	(14,818		)	(73,876		)	(13,588		)
Long lived assets, net	64,337			28,365			65,530			28,269
Inventory	$	57,854		$	25,975		$	56,960		$	25,730

Geographic distribution of our sales is summarized in the following table (in thousands):

Three Months Ended March 31,	2014		2013		% Inc/Decr
Domestic sales	$	41,608	$	38,965	6.8
International sales	21,650		20,336		6.5
Total sales	$	63,258	$	59,301	6.7